Investor Presentaiton

Key Milestones targeted for future SUN PHARMA • Enhance share of specialty/branded business US Business • Continue to focus on complex generics and high entry barrier segments •Ensure broad product offering to customers across multiple dosage forms • Gain critical mass in key therapeutic segments India Business •Improve productivity of India business. • Maintain leadership position in a fiercely competitive market . • Continuously innovate to ensure high brand equity with doctors • Gain critical mass in key emerging markets ROW Business . Enhance product basket in emerging markets •Improve profitability in developed European markets © Sun Pharmaceutical Industries Limited. All Rights Reserved. 42 52

View entire presentation